Cargando…

Ovarian Cancer: Current Treatment and Patient Management

Detalles Bibliográficos
Autores principales:	Monk, Bradley J., Anastasia, Paula J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679040/ https://www.ncbi.nlm.nih.gov/pubmed/29152388

Ejemplares similares

The role of immune checkpoint inhibition in the treatment of ovarian cancer
por: Gaillard, Stéphanie L., et al.
Publicado: (2016)

Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease
por: Arend, Rebecca C., et al.
Publicado: (2021)

Safety and management of niraparib monotherapy in ovarian cancer clinical trials
por: Monk, Bradley J, et al.
Publicado: (2023)

Updates on drug discovery in ovarian cancer
por: Gibson, Steven J, et al.
Publicado: (2014)

Current Approaches and Challenges in Managing and Monitoring Treatment Response in Ovarian Cancer
por: Marcus, Charlotte S, et al.
Publicado: (2014)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?
por: Herzog, Thomas J., et al.
Publicado: (2017)

How Do You Triage Abdominal Pain in a Patient With Ovarian Cancer?
por: Anastasia, Paula
Publicado: (2014)

Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence
por: Mascilini, Floriana, et al.
Publicado: (2014)

Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives
por: Awada, Ahmad, et al.
Publicado: (2022)

Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
por: Ahmed, Nuzhat, et al.
Publicado: (2020)

Current Status of Patient-Derived Ovarian Cancer Models
por: Maru, Yoshiaki, et al.
Publicado: (2019)

Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives
por: McClung, E Clair, et al.
Publicado: (2016)

Emerging treatment options for management of malignant ascites in patients with ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2012)

Patient selection and targeted treatment in the management of platinum-resistant ovarian cancer
por: Leamon, Christopher P, et al.
Publicado: (2013)

Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer
por: Garrido, Maritza P., et al.
Publicado: (2021)

Kinase Inhibitors in the Treatment of Ovarian Cancer: Current State and Future Promises
por: Skorda, Aikaterini, et al.
Publicado: (2022)

Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer
por: Rinne, Natasha, et al.
Publicado: (2021)

Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer
por: Markman, Maurie
Publicado: (2011)

Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options
por: Garg, Vikas, et al.
Publicado: (2023)

Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies
por: Mantia-Smaldone, Gina M, et al.
Publicado: (2010)

Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis
por: Borella, Fulvio, et al.
Publicado: (2020)

Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment
por: Tymon-Rosario, Joan, et al.
Publicado: (2021)

Management of ovarian cysts and cancer in pregnancy
por: de Haan, J., et al.
Publicado: (2015)

Current status of bevacizumab in advanced ovarian cancer
por: Tomao, Federica, et al.
Publicado: (2013)

Current treatment options for the management of esophageal cancer
por: Mawhinney, Mark R, et al.
Publicado: (2012)

Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives
por: Singh, Alka, et al.
Publicado: (2019)

Clinical utility of targeted treatments in the management of epithelial ovarian cancer
por: Twu, Cheryl, et al.
Publicado: (2012)

Diagnosis and Management of Pediatric Ovarian Torsion in the Emergency Department: Current Insights
por: Scheier, Eric
Publicado: (2022)

Epithelial ovarian cancer risk: A review of the current genetic landscape
por: Flaum, Nicola, et al.
Publicado: (2019)

Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11–001
por: Miles, Brett, et al.
Publicado: (2017)

The Potential Roles of Epigallocatechin-3-Gallate in the Treatment of Ovarian Cancer: Current State of Knowledge
por: Bimonte, Sabrina, et al.
Publicado: (2020)

Olaparib in the management of ovarian cancer
por: Bixel, Kristin, et al.
Publicado: (2015)

Ovarian cancer recurrence: is the definition of platinum resistance modified by PARPi and other intervening treatments? The evolving landscape in the management of platinum-resistant ovarian cancer
por: Flynn, Michael J., et al.
Publicado: (2022)

Ovarian Cancer Previvors: How to manage these patients?
por: Carvalho, Jesus Paula, et al.
Publicado: (2019)

Developments in Genetics: Better Management of Ovarian Cancer Patients
por: Maioru, Ovidiu-Virgil, et al.
Publicado: (2023)

Current status of maintenance therapy for advanced ovarian cancer
por: Hope, Joanie Mayer, et al.
Publicado: (2010)

Transvaginal ultrasonography in ovarian cancer screening: current perspectives
por: van Nagell, John R, et al.
Publicado: (2013)

Ovarian cancer screening—Current status, future directions()
por: Menon, Usha, et al.
Publicado: (2014)

Ovarian cancer: Pathogenesis and current recommendations for prophylactic surgery
por: Budiana, I Nyoman Gede, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_np9oolie55a6u4rbiksr3plln3